RecruitingNot ApplicableNCT04532190
Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Sponsor
University of Calgary
Enrollment
30 participants
Start Date
Mar 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
Attention-Deficit/Hyperactivity Disorder (ADHD) is characterized by poor attention, impulsivity, hyperactivity and emotional-motivational dysregulation. Here, we will test if theta burst repetitive transcranial magnetic stimulation (rTMS) can reduce the symptoms of ADHD.
Eligibility
Min Age: 9 YearsMax Age: 15 Years
Inclusion Criteria5
- Diagnosis of ADHD
- 9-15 years old
- IQ greater than 80
- English fluency (to enable consent/assent)
- If on medication, must have been on the same type and dosage for at least 3 months.
Exclusion Criteria4
- Diagnosis of mania, psychosis, or bipolar disorder
- Impediments to TMS or MRI (i.e. metal implants in body)
- Prior electroconvulsive therapy or vagus nerve stimulation
- Diagnosis of Autism Spectrum Disorder.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICErTMS
Repetitive transcranial magnetic stimulation (rTMS)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04532190
Related Trials
Effects of Probiotics on the Gut-brain Axis in Children
NCT074596991 location
Smartphone-based Intervention for Young Adults With ADHD
NCT076542051 location
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
NCT072262191 location
Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)
NCT075923901 location
A Random Controlled Trial of Home-based Digital Therapy for Treating ADHD in Children
NCT075529091 location